Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. RMS often arise from myogenic precursors and displays a poorly differentiated skeletal muscle phenotype most closely resembling regenerating muscle. GSK3β is a ubiquitously expressed serine-threonine kinase capable of repressin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Bharathy, Narendra, Svalina, Matthew N., Settelmeyer, Teagan P., Cleary, Megan M., Berlow, Noah E., Airhart, Susan D., Xiang, Sunny, Keck, James, Hayden, James B., Shern, Jack F., Mansoor, Atiya, Lathara, Melvin, Srinivasa, Ganapati, Langenau, David M., Keller, Charles
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609896/
https://ncbi.nlm.nih.gov/pubmed/28968964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18520
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars